Climb Bio (CLYM) EPS (Basic) (2020 - 2026)

Climb Bio (CLYM) posted EPS (Basic) of -$0.68 for Q1 2026, down 56.82% on a QoQ basis from -$0.43 in Q4 2025, and down 114.2% year-over-year from $4.75 in Q1 2025.

Climb Bio (CLYM) EPS (Basic) (2020 - 2026) Analysis & Trends

Climb Bio's EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.68 for Q1 2026.

  • Quarterly EPS (Basic) fell 114.2% year-over-year to -$0.68 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.44 (changed 0.29% YoY) and the FY2025 annual result came in at -$1.05, up 50.55% from the prior year.
  • EPS (Basic) was -$0.68 for Q1 2026 at Climb Bio, down from -$0.43 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.1 in Q1 2024 and bottomed at -$1.9 in Q2 2024.
  • A 5-year average of -$0.48 and a median of -$0.32 in 2025 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2024 — EPS (Basic) tumbled 550.93% — and 2025, when it soared 93.35%.
  • Climb Bio's EPS (Basic) stood at -$0.3 in 2022, then plunged by 209.36% to -$0.91 in 2023, then soared by 80.34% to -$0.18 in 2024, then plunged by 140.01% to -$0.43 in 2025, then sank by 56.82% to -$0.68 in 2026.
  • Business Quant data shows CLYM's EPS (Basic) at -$0.68 in Q1 2026, -$0.43 in Q4 2025, and -$0.21 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Climb Bio 875.44 Mn 875.44 Mn - -0.68

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.68
Dec 31, 2025 -0.43
Sep 30, 2025 -0.21
Jun 30, 2025 -0.13
Mar 31, 2025 -0.32
Dec 31, 2024 -0.18
Sep 30, 2024 -0.15
Jun 30, 2024 -1.90
Mar 31, 2024 -0.10
Dec 31, 2023 -0.91
Sep 30, 2023 -0.19
Jun 30, 2023 -0.29
Mar 31, 2023 -0.94
Dec 31, 2022 -0.30
Sep 30, 2022 -0.37
Jun 30, 2022 -0.56
Mar 31, 2022 -0.50
Dec 31, 2021 -0.86
Sep 30, 2021 -0.70
Jun 30, 2021 -3.11